Iqvia Holdings Inc.
IQVQ3 2025(IQV Q2 FY2025)Estimated4.5% AI
AI Revenue %
4.5%
AI Fair Value
$983.3M
AI Revenue (Q)
$339.8M
Total Revenue (Q)
$7.6B
Source: SEC EDGAR 10-Q Filing
View 10-Q on SEC.govAnalysis
No AI revenue breakout. TAS segment was $1,628M (40.5% of $4,017M total). IQVIA's TAS growth (8.9% YoY) outpacing total company growth (5.3% YoY) suggests technology/AI-driven products gaining share. AI penetration of TAS estimated at ~11% = ~$179M, or ~4.5% of total revenue.
Analyzed by claude-opus-4-6
Quoted Figures
Technology & Analytics Solutions revenues $1,628M; Total revenues $4,017M for Q2 2025
10-Q filed 2025-06-30, Segment Data
AI Products Identified (Ring 1)
IQVIA Connected Intelligence (Healthcare-grade AI)AI-powered clinical trial optimizationAI-driven real world evidence analyticsAI-enhanced commercial analytics
AI-Enabled Items (Ring 2 — Not Counted)
These items use AI but are not counted in the AI revenue estimate because they primarily serve non-AI functions.
Traditional data subscriptionsLegacy analytics platformsClinical research services (non-AI CRO)Contract sales and medical solutions
Confidence Tier
EstimatedNo direct AI revenue disclosure — estimated from product mix